Nifty
Sensex
:
:
11937.65
40707.31
40.85 (0.34%)
162.94 (0.40%)

Pharmaceuticals & Drugs - Domestic

Rating :
79/99  (View)

BSE: 500488 | NSE: ABBOTINDIA

15885.15
89.10 (0.56%)
21-Oct-2020 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  15843.50
  •  16020.10
  •  15715.75
  •  15796.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  4699
  •  746.44
  •  18679.75
  •  10350.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 33,760.04
  • 51.44
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 31,562.67
  • 1.57%
  • 13.10

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 74.99%
  • 0.00%
  • 15.27%
  • FII
  • DII
  • Others
  • 1.15%
  • 5.44%
  • 3.15%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 9.38
  • 7.46

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 15.76
  • 7.64

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 18.36
  • 13.90

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 36.60
  • 38.15
  • 39.85

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.15
  • 14.15
  • 14.15

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.18
  • 24.31
  • 26.21

Quarterly Results

Standalone Figures in Rs. Crores

Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0
0
0
0
0
0
0
0
0
0
0
0
EBITDA
0
0
0
0
0
0
0
0
0
0
0
0
EBIDTM
0%
0%
0%
0%
0%
0%
0%
0%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
0
0
0
0
0
0
0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
PAT
0
0
0
0
0
0
0
0
0
0
0
0
PATM
0%
0%
0%
0%
0%
0%
0%
0%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update


  • Abbott gets nod from DCGI for once-a-day formulation ‘Ivabradine’
    3rd Sep 2020, 14:03 PM

    The company plans to launch Ivabradine prolonged release tablets in the Indian market in the coming weeks

    Read More
  • Abbott India reports 54% rise in Q1 net profit
    10th Aug 2020, 09:26 AM

    Total income of the company increased by 6.17% at Rs 1,091.90 crore for Q1FY21

    Read More
  • Abbott India - Quarterly Results
    7th Aug 2020, 22:40 PM

    Read More
  • Abbott, 1mg bring continuous glucose monitoring solutions closer to Indian homes
    31st Jul 2020, 12:25 PM

    Patients in India can upload a healthcare practitioner’s prescription and purchase the product online on 1mg

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.